U.S. government shutdown / DOE funding delays
Many projects depend directly or indirectly on DOE grants, cooperative agreements, or loan guarantees.
- Scope
- Postponed grants, slower loan guarantees, and delayed cost-share funding
- Materiality
- high
LanzaTech Global, Inc.
LanzaTech Global, Inc. develops and commercializes gas fermentation technology that converts waste carbon streams into ethanol and other products. The company primarily monetizes its platform through technology licensing and royalties, while also expanding into project ownership, operatorship, and research and development services for fuels and chemicals.
−134,2 %
−87,7 %
+12,6 %
1.43
1.41
| % | |
|---|---|
| Technology licensing and royalties | 45% Licenses for customers to build, own, and operate facilities using LanzaTech's process, with royalties tied to revenue generated. |
| One-time project and commercialization revenue | 35% Non-recurring revenue from project services, engineering, equipment-related work, and other commercialization activities. |
| Microbes and media | 10% Sales of proprietary microbes and media used in fermentation and process deployment. |
| Research and development services | 5% Contract R&D and biocatalyst development services for fuels and chemicals applications. |
| Joint venture and platform offerings | 5% Joint offerings such as CirculAir™ that combine LanzaTech technology with partner platforms for SAF and renewable diesel. |
LanzaTech sells mainly to industrial customers, project developers, and strategic partners that want to convert waste...
- Industrial plant operatorsprimary
Customers that build, own, and operate facilities using LanzaTech's technology and pay royalties on output or revenue.
- Project development partnersprimary
Partners that buy project services, engineering, and commercialization support to move plants from concept to operation.
- Strategic fuel and chemical partnerssecondary
Companies pursuing sustainable aviation fuel, renewable diesel, and chemical production using waste feedstocks.
- Joint venture and co-owned facilitiessecondary
Partners in commercial plants such as the Shougang LanzaTech venture and other international deployments.
- Government-backed project sponsorssecondary
Customers or counterparties whose projects depend on DOE grants, cooperative agreements, or loan guarantees.
LanzaTech is headquartered in the United States but its commercial footprint is international, with operating plants...
- •United States headquarters and key financing/risk exposure
- •China commercial base through the Shougang LanzaTech joint venture
- •India and Belgium host additional commercial plants
- •Other projects are in development across multiple countries
- •Government-dependent U.S. projects can delay revenue timing
LanzaTech is shifting from one-off project execution toward a cohort-based commercialization model that sequences...
01
Cohort-based commercializationshort-term
Improves execution discipline and creates a staged path from services to recurring revenue.
02
Liquidity preservation and cost controlshort-term
The company remains loss-making and needs cash runway to fund development.
03
Funding diversificationmedium-term
Reduces dependence on DOE-linked milestones and lowers project timing risk.
04
Expand control in the biorefining value chainmedium-term
Ownership and operatorship can improve product access and economics versus pure licensing.
LanzaTech’s business is exposed to project-financing risk, customer adoption risk, and execution risk because...
Project financing and offtake risk
Revenue depends on projects reaching financing close and securing customer offtake before deployment.
- Scope
- Earlier cohort projects and new commercial plants
- Materiality
- high
Liquidity and going-concern pressure
The company has not achieved operating profitability and continues to fund losses with external capital.
- Scope
- Cash runway, debt repayment, and future financing terms
- Materiality
- high
Execution risk in first-of-a-kind deployments
Gas fermentation plants require technical, regulatory, and partner coordination across jurisdictions.
- Scope
- Commercial plants in China, India, Belgium, and new cohorts
- Materiality
- medium
Revenue recognition across licensing, royalties, and project services
Can shift reported revenue between recurring and one-time categories
Fair value measurement of Brookfield-related instruments
Can materially affect other income/expense and net loss
Stock-based compensation and warrant/SAFE valuation
Affects operating expenses and reported earnings volatility
Going-concern and liquidity assumptions
May influence disclosures, estimates, and financing classification
LENZ Therapeutics, Inc.
LENZ · Biological Products, (No Diagnostic Substances)
LENZ Therapeutics is a U.S.-based pre-commercial biopharmaceutical company focused on developing and commercializing VIZZ, an aceclidine-based eye drop for presbyopia.
ENTRAVISION COMMUNICATIONS CORP
EVC · Television Broadcasting Stations
ESTABLISHMENT LABS HOLDINGS INC.
ESTA · Orthopedic, Prosthetic & Surgical Appliances & Supplies
SenesTech, Inc.
SNES · Agricultural Chemicals
WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
WAB · Railroad Equipment
Wabtec is a U.S.-based rail technology company that designs and supplies locomotives, braking systems, couplers, doors, pantographs, and related control and service solutions.
GLOBAL TECHNOLOGIES LTD
GTLL · Radio & Tv Broadcasting & Communications Equipment
: 28.4.2026